EMBL-EBI | Chemical Biology | ChEBI
Example searches: iron*, InChI=1S/CH4O/c1-2/h2H,1H3, caffeine | Advanced Search
CHEBI:750071 - benralizumab
| ChEBI ID | CHEBI:750071 |
| ChEBI Name | benralizumab |
| Stars | |
| Last Modified | 29 June 2026 |
| Submitter | chembl-etl |
| Roles Classification |
|---|
| Applications: | anti-asthmatic agent Any compound that has anti-asthmatic effects. dermatologic drug A drug used to treat or prevent skin disorders or for the routine care of skin. antineoplastic agent A substance that inhibits or prevents the proliferation of neoplasms. |
| ChEBI Ontology |
|---|
| Outgoing Relation(s) |
| benralizumab (CHEBI:750071) has role anti-asthmatic agent (CHEBI:65023) |
| benralizumab (CHEBI:750071) has role antineoplastic agent (CHEBI:35610) |
| benralizumab (CHEBI:750071) has role dermatologic drug (CHEBI:50177) |
| benralizumab (CHEBI:750071) is a organic molecular entity (CHEBI:50860) |
| Synonyms | Source |
|---|---|
| Benralizumab | ChEMBL |
| BIW-8405 | ChEMBL |
| MEDI-563 | ChEMBL |
| Brand Name | Source |
|---|---|
| Fasenra | ChEMBL |